Switch to:

CRISPR Therapeutics AG Total Liabilities

: $141.72 Mil (As of Sep. 2020)
View and export this data going back to 2016. Start your Free Trial

CRISPR Therapeutics AG's Total Liabilities for the quarter that ended in Sep. 2020 was $141.72 Mil.

CRISPR Therapeutics AG's quarterly Total Liabilities increased from Mar. 2020 ($121.20 Mil) to Jun. 2020 ($135.86 Mil) and increased from Jun. 2020 ($135.86 Mil) to Sep. 2020 ($141.72 Mil).

CRISPR Therapeutics AG's annual Total Liabilities increased from Dec. 2017 ($83.51 Mil) to Dec. 2018 ($96.82 Mil) and increased from Dec. 2018 ($96.82 Mil) to Dec. 2019 ($127.33 Mil).


CRISPR Therapeutics AG Total Liabilities Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Total Liabilities Premium Member Only 188.55 112.12 83.51 96.82 127.33

CRISPR Therapeutics AG Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Total Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.71 127.33 121.20 135.86 141.72

CRISPR Therapeutics AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CRISPR Therapeutics AG's Total Liabilities for the fiscal year that ended in Dec. 2019 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=57.106+(44.05+14.395
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+11.776+0)
=127.33

Total Liabilities=Total Assets (A: Dec. 2019 )-Total Equity (A: Dec. 2019 )
=1066.752-939.425
=127.33

CRISPR Therapeutics AG's Total Liabilities for the quarter that ended in Sep. 2020 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=84.149+(38.57+7.222
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+11.776+0)
=141.72

Total Liabilities=Total Assets (Q: Sep. 2020 )-Total Equity (Q: Sep. 2020 )
=1485.018-1343.301
=141.72

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


CRISPR Therapeutics AG Total Liabilities Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)